MedTrace Logo

Circadian High Intensity Interval Training Study

NCT03553524 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2022-05-24

No results posted yet for this study

Summary

High intensity interval training (HIIT) is a promising intervention for treatment and prevention of type 2 diabetes. In spite of the interplay between circadian rhythms and exercise, the time of day in which the most robust adaption to HIIT can be achieved is unknown. The main goal of the study is to compare the efficacy of morning and afternoon HIIT in lowering blood glucose values in participants with type 2 diabetes.

Conditions

Interventions

OTHER

morning HIIT --> afternoon HIIT

Arm 1 will start with morning HIIT at visit 2 and afternoon HIIT at visit 3

OTHER

afternoon HIIT --> morning HIIT

Arm 2 will start with afternoon HIIT at visit 2 and morning HIIT at visit 3

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
45 Years
Max Age
68 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-30
Primary Completion
2022-07-30
Completion
2022-10-30

Countries

  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03553524 on ClinicalTrials.gov